Publication | Closed Access
Citalopram and Cannabidiol
45
Citations
53
References
2021
Year
Further pharmacokinetic examination of the interaction between CBD and citalopram/escitalopram is clearly warranted, and clinicians should be vigilant around the possibility of treatment-emergent adverse effects when CBD is introduced to patients taking these antidepressants.
| Year | Citations | |
|---|---|---|
Page 1
Page 1